Compass Therapeutics, Inc. (CMPX)
Compass Therapeutics, Inc. (CMPX) has reported earnings 14 times since Nov 01, 2021. The stock moves an average of ±6.45% the day after reporting, closing higher 57.1% of the time. Its largest post-earnings gain was +31.79% (Nov 01, 2021) and its largest decline was -6.4% (Nov 09, 2023). The next earnings report is predicted for 2026-08-12 (approximate).
Earnings reactions
How CMPX moved on each past earnings report.
Earnings Impact
Total Earnings
14
Avg Abs. Movement
±6.45%
Positive %
57.1%
Negative %
42.9%
Historical Earnings Statistics
| Date | Timing | Earnings move | SEC Filing |
|---|---|---|---|
| May 05, 2026 | ☀ PRE | +1.55% | open_in_new |
| Mar 05, 2026 | ☀ PRE | -2.81% | open_in_new |
| Nov 05, 2025 | ☀ PRE | +0.79% | open_in_new |
| Aug 11, 2025 | ☀ PRE | +23.7% | open_in_new |
Earnings Count
14
Total earnings in dataset
Avg Abs. Movement
±6.45%
Avg % price change on earnings
Institutional ownership
Holdings as of Mar 31, 2026 · SEC 13-F
SEC Filing Types
Recent SEC Filings
10 most recent| Form | Date Filed | View on EDGAR |
|---|---|---|
| 8-K | 20260701 | open_in_new SEC.gov |
| 8-K | 20260623 | open_in_new SEC.gov |
| 8-K | 20260611 | open_in_new SEC.gov |
| SCHEDULE 13G/A | 20260515 | open_in_new SEC.gov |
| 10-Q | 20260505 | open_in_new SEC.gov |
| 8-K | 20260505 | open_in_new SEC.gov |
| 4/A | 20260430 | open_in_new SEC.gov |
| 4/A | 20260430 | open_in_new SEC.gov |
| 4 | 20260429 | open_in_new SEC.gov |
| 4 | 20260429 | open_in_new SEC.gov |
Frequently asked about CMPX earnings
When does Compass Therapeutics, Inc. report earnings next? expand_more
Compass Therapeutics, Inc. (CMPX)'s next earnings date is approximate for 2026-08-12. This is a prediction based on its historical quarterly reporting pattern, not a company-confirmed date.
How much does CMPX stock move after earnings? expand_more
Over 14 reports, CMPX has moved an average of ±6.45% the session after earnings, closing higher 57.1% of the time.
What was CMPX's biggest post-earnings move? expand_more
CMPX's largest post-earnings gain on record was +31.79% on Nov 01, 2021, and its largest decline was -6.4% on Nov 09, 2023.
Where can I find Compass Therapeutics, Inc.'s SEC filings? expand_more
All of Compass Therapeutics, Inc.'s SEC filings — 10-K, 10-Q, 8-K and more — are listed in the SEC filings section on this page, each linking to the original document on SEC.gov.
Sector peers
- Aardvark Therapeutics, Inc. (AARD) earnings history chevron_right
- AbCellera Biologics Inc. Common Shares (ABCL) earnings history chevron_right
- ABEONA THERAPEUTICS INC. (ABEO) earnings history chevron_right
- Acumen Pharmaceuticals, Inc. Common Stock (ABOS) earnings history chevron_right
- Arbutus Biopharma Corp (ABUS) earnings history chevron_right
- ABVC BioPharma, Inc. Common Stock (ABVC) earnings history chevron_right
- ACADIA PHARMACEUTICALS INC (ACAD) earnings history chevron_right
- Adicet Bio, Inc. Common Stock (ACET) earnings history chevron_right
- Acadia Healthcare Company, Inc. Common Stock (ACHC) earnings history chevron_right
- Achieve Life Sciences, Inc. Common Shares (ACHV) earnings history chevron_right